HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,821-2,832 of 4,505
Device study icon
CompletedNCT05053451

Brain Stimulation, Clinical Symptoms and Cognition

Official study title

Transcranial Direct Current Stimulation (tDCS) Studies of Auditory Hallucinations, Negative Symptoms and Cognition in Schizophrenia

This study has finished and is no longer accepting participants.

In Sacramento
SchizophreniaDevice studyAges 18–65
Countries
United States
Sponsor
University of California, Davis
Behavioral study icon
CompletedNCT02911519

Brief Group Psychoeducation for Schizophrenia

Official study title

Efficacy of a Brief Group Psychoeducation Program Aimed at Patients With Schizophrenia and Their Families: A Clinical Controlled Trial

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaInterventional studyAges 18–65
Countries
Sponsor
Salud Mental Integral S.A.S.
Drug study icon
CompletedNCT00821600

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of people with Schizophrenia

Official study title

Single-Dose, Open-Label Pilot Study to Explore the Pharmacokinetics, Safety and Tolerability of a Gluteal Intramuscular Injection of a 4-Week Long-Acting Injectable Formulation of Risperidone in Patients With Chronic Stable Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT01164059

Comparing Older and Newer Antipsychotic Treatment Strategies

About this title

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

Read the official source — NCT01164059
What is this study about?

This study evaluated the effectiveness of Olanzapine for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Aachen
SchizophreniaMedication studyAges 18–65
Countries
Germany
Sponsor
University of Bremen
Drug study icon
CompletedNCT02832037

study of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Official study title

A Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–50
Countries
United States, Canada, United Kingdom, + 8 others
Sponsor
Boehringer Ingelheim
Drug study icon
TerminatedNCT00044083

study of Tolcapone for Cognition in Schizophrenia

Official study title

Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Tolcapone and Entacapone on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype

This study ended early.

In Bethesda
SchizophreniaMedication studyAges 18–50
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT07609953

Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia

Official study title

Effectiveness of Cognitive Behavioral Therapy as Adjunctive Therapy on Cognitive Function and Serum Brain-Derived Neurotrophic Factor Levels in Patients With Schizophrenia Receiving Risperidone Therapy

This study has finished and is no longer accepting participants.

In Makassar
SchizophreniaMedication studyAges 20–50
Countries
Indonesia
Sponsor
Hasanuddin University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.